
1. Emerging Infections
2. Global Health
3. Epidemiology of infectious diseases
4. Clinical microbiology and diagnostics
5. Bioterrorism Preparedness
6. Surveillance for communicable diseases
7. Antimicrobial resistance
Education and Training
- Fellow in Infectious Diseases, Medicine, Duke University, 2001 - 2002
- Fellow in Infectious Diseases, Medicine, Duke University, 1999 - 2000
- Medical Resident, Medicine, Duke University, 1994 - 1997
- M.D., Duke University, 1994
Grants
- Antibacterial Resistance Leadership Group (ARLG)
- Sepsis Characterization in Kilimanjaro (R01)
- Interdisciplinary Research Training Program in AIDS
- RADx-UP CDCC
- Vaccine and Treatment Evaluation Units (VTEU)
- Duke CTSA (TL1)
- HERO Program, HERO Registry, HERO-HCQ Trial
- Duke RDS2 (Respondent-Driven Sampling, Respiratory Disease Surveillance) the SNOWBALL Sampling Study
- CIVICS Component C - Option 13A
- Duke Resident Physician-Scientist Program - NIAID
- Clinical Vaccine Safety Evaluation - Contributing Site - Task COVID - Optional Task 3
- VTEU Task Order 13-0045.C1D1.0062 - Task C Option 1
- Novel Diagnostics to Improve Antimicrobial Stewardship for Acute Respiratory Tract Infections in Resource-Limited Settings
- Investigating Febrile Deaths in Tanzania (INDITe)
- ID NOW Clinical Evaluation
- IMR PSA - Tyffany Locklear Ensemble Study
- IMR PSA - Deborah Murray Ensemble Study
- VTEU Task Area C Option 1 Protocol 15-0020.B1C1.0040
- CIVICS Component C - Option 1
- Mapping Epigenetic Memory of Exposure New To Observe (MEMENTO)
- Clinical Evaluation of the ID NOW¿ 1.1 COVID-19 Assay
- Adaptive COVID-19 Treatment Trial (ACTT)
- VTEU 18-0010.B1C1.0120_Task C Option 1
- Clinical Evaluation of the ID NOW COVID-19 Assay
- VTEU Task Area A - FY.2020.A1B1C1D1.0123 - Option 1
- VTEU Task Area C Option 2-3 Protocol 15-0020.B1C1.0040
- Postdoctoral Training in Genomic Medicine Research
- IPA- Lawrence Park